Ignite Creation Date:
2025-12-24 @ 7:08 PM
Ignite Modification Date:
2025-12-27 @ 6:13 AM
Study NCT ID:
NCT00882557
Status:
COMPLETED
Last Update Posted:
2018-02-06
First Post:
2009-04-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate Daptomycin Given During Dialysis and After Dialysis
Sponsor:
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-04-29
Start Date Type:
ACTUAL
Primary Completion Date:
2009-07-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-07-17
Completion Date Type:
ACTUAL
First Submit Date:
2009-04-15
First Submit QC Date:
None
Study First Post Date:
2009-04-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-07-19
Results First Submit QC Date:
None
Results First Post Date:
2011-10-25
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-01-10
Last Update Post Date:
2018-02-06
Last Update Post Date Type:
ACTUAL